Literature DB >> 15750363

The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study.

Joseph T F Lau1, P C Leung, E L Y Wong, C Fong, K F Cheng, S C Zhang, C W K Lam, V Wong, K M Choy, W M Ko.   

Abstract

OBJECTIVES: To investigate the efficacy of an herbal formula in the prevention of severe acute respiratory syndrome (SARS) transmission among health care workers. The secondary objectives are to investigate quality of life (QOL) and symptomology changes among supplement users, and to evaluate the safety of this formula.
DESIGN: Controlled clinical trial. SETTINGS: Hong Kong during epidemic of SARS.
SUBJECTS: Two cohorts of health care workers from 11 hospitals in Hong Kong, 1 using an herbal supplement for a 2-week period (n = 1063) and a control cohort comprising all other health care workers who did not receive the supplement (n = 36,111) were compared prospectively.
INTERVENTIONS: Taking an herbal supplement for a 2-week period. OUTCOME MEASURES: SARS attack rates and changes in quality of life and influenza-like symptoms were also examined at three timepoints among herbal supplement users.
RESULTS: None of the health care workers who used the supplement subsequently contracted SARS compared to 0.4% of the health care workers who did not use the supplement (p = 0.014). Improvements in influenza-like symptoms and quality of life measurements were also observed among herbal supplement users. Less than 2% reported minor adverse events.
CONCLUSION: The results of this pilot study suggest that there is a good potential of using Traditional Chinese Medicine (TCM) supplements to prevent the spread of SARS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750363     DOI: 10.1089/acm.2005.11.49

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  22 in total

Review 1.  Physical interventions to interrupt or reduce the spread of respiratory viruses.

Authors:  Tom Jefferson; Chris B Del Mar; Liz Dooley; Eliana Ferroni; Lubna A Al-Ansary; Ghada A Bawazeer; Mieke L van Driel; Sreekumaran Nair; Mark A Jones; Sarah Thorning; John M Conly
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

Review 2.  Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Authors:  Yinan Xiao; Hanyue Xu; Wen Guo; Yunuo Zhao; Yuling Luo; Ming Wang; Zhiyao He; Zhenyu Ding; Jiyan Liu; Lei Deng; Fushen Sha; Xuelei Ma
Journal:  Mol Biomed       Date:  2020-12-03

Review 3.  Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review.

Authors:  Fatemeh Barati; Mahdi Pouresmaieli; Elena Ekrami; Sahar Asghari; Farzad Ramezani Ziarani; Matin Mamoudifard
Journal:  Biol Proced Online       Date:  2020-07-23       Impact factor: 3.244

Review 4.  Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review.

Authors:  Weijia Xing; Gilles Hejblum; Gabriel M Leung; Alain-Jacques Valleron
Journal:  PLoS Med       Date:  2010-05-04       Impact factor: 11.069

5.  Cochrane Review: Interventions for the interruption or reduction of the spread of respiratory viruses.

Authors:  Tom Jefferson; Ruth Foxlee; Chris Del Mar; Liz Dooley; Eliana Ferroni; Bill Hewak; Adi Prabhala; Sreekumaran Nair; Alessandro Rivetti
Journal:  Evid Based Child Health       Date:  2008-12-10

6.  Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.

Authors:  Lisa M Alleva; Charles Cai; Ian A Clark
Journal:  Evid Based Complement Alternat Med       Date:  2009-09-24       Impact factor: 2.629

7.  Efficacy of Traditional Chinese Medicine on COVID-19: Two Case Reports.

Authors:  Zi Zhou Zheng; Ning Ning Ma; Lily Li; Dan Jiang
Journal:  Med Acupunct       Date:  2021-02-16

8.  Physical interventions to interrupt or reduce the spread of respiratory viruses.

Authors:  Tom Jefferson; Chris B Del Mar; Liz Dooley; Eliana Ferroni; Lubna A Al-Ansary; Ghada A Bawazeer; Mieke L van Driel; Mark A Jones; Sarah Thorning; Elaine M Beller; Justin Clark; Tammy C Hoffmann; Paul P Glasziou; John M Conly
Journal:  Cochrane Database Syst Rev       Date:  2020-11-20

Review 9.  Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.

Authors:  Yujun Tang; Jiajia Liu; Dingyi Zhang; Zhenghao Xu; Jinjun Ji; Chengping Wen
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

10.  Traditional Chinese medicine for corona virus disease 2019: A protocol for systematic review.

Authors:  Ju Huang; Liu Wu; Xiaodan Ren; Xinhui Wu; Yong Chen; Guoping Ran; Anming Huang; Liangxin Huang; Dan Zhong
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.